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1. INTRODUCTION 22 
Chlorpromazine (CPZ) is an anti-psychotic agent that belongs to the family of 23 
phenothiazines. From a clinical standpoint, it is widely used to treat psychotic disorders 24 
such as schizophrenia or manic-depression. Unfortunately, CPZ has been often reported 25 
as photosensitizing agent, with undesirable side effects such as included phototoxic and 26 
photoallergic reactions in humans.1-8 In addition, CPZ photoproducts like promazine 27 
(PMZ) and chlorpromazine sulfoxide (CPZSO) have revealed toxic effects on primary 28 
cultures of hepatocytes.9 More recently, toxic epidermal necrolysis induced by CPZ upon 29 
sunlight exposure has been noticed.10 The phototoxic activity of drug can be related with 30 
their genotoxic and mutagenic potential. In this context, CPZ is able to promote DNA 31 
photodamage.6, 11, 12  32 
From the urine of psychiatric patients, CPZ metabolites have been identified13 revealing 33 
that the metabolic pathways during Phase I led to demethylation, sulphoxidation and 34 
hydroxylation.14, 15 Thus, biotransformation of CPZ results in a variety of derivatives, 35 
which have be considered for establishing the pharmacological and toxicological 36 
profile.16 37 
As a general rule, metabolism converts hydrophobic chemicals into more hydrophilic 38 
derivatives that can be easily eliminated through the urine. However, in certain cases, 39 
drug-metabolizing enzymes can also produce electrophilic metabolites that react with 40 
cellular macromolecules such as DNA, RNA, and proteins, causing cell death and organ 41 
toxicity.17 42 
Assessment of the phototoxic potential of sunlight-absorbing drugs is highly 43 
recommended by Health authorities (FDA; EMEA)18, 19 but the influence of metabolism 44 
is not considered in the appraisal. For that reason, identification of reactive drug 45 
metabolites with phototoxic or adduct forming capability is a major challenge. Hence, the 46 
goal of the present work is to investigate the possible photo(geno)toxic potential of drug 47 
metabolites, using chlorpromazine as an established reference compound. In this case, the 48 
metabolites selected for the study (see Figure 1) are demethylchlopromazine (DMCPZ), 49 
didemethylchlopromazine (DDMCPZ) and chlorpromazine sulfoxide (CPZSO). Both 50 
DMCPZ and DDMCPZ maintain the CPZ chromophore unaltered, so modulation of the 51 
photobiological effects would be associated with the nature of the aminoalkyl side-chain. 52 
By contrast, CPZSO displays a modified tricycle aromatic core, which could be 53 
responsible for major changes in the phototoxicological properties. 54 
The proposed multidisciplinary approach encompass from photochemical (steady-state 55 
and laser flash photolysis) to spectroscopic (Electron Paramagnetic Resonance, EPR) and 56 
biological studies (neutral red uptake test, gel electrophoresis, comet assay) in order to 57 
obtain mechanistic insight into the involved process. 58 
 59 
  60 
Figure 1. Chemical structures of CPZ, DMCPZ, DDMCPZ, PMZ and CPZSO.  61 
 62 
 63 
2. MATERIALS AND METHODS 64 
2.1 Chemicals.  65 
All solvents (HPLC grade) and reagents were commercially available and used without 66 
additional purification. Chlorpromazine, promazine, in vitro toxicology assay kit, neutral 67 
red based and DNA repair enzymes E. coli formamidopyrimidine DNA glycosylase 68 
(Fpg), E. coli endonuclease III (Endo III) were purchased from Sigma Aldrich (Madrid, 69 
Spain). Supercoiled circular pBR322 DNA, SYBR Safe DNA gel stain and DNA repair 70 
enzyme T4 endonuclease V (Endo V) were provided by Roche Diagnostics (Barcelona, 71 
Spain), Invitrogen (Madrid, Spain) and Ecogen (Barcelona, Spain), respectively. 72 
Phosphate buffered saline solution (PBS, pH 7.4, 0.01 M) was prepared by dissolving 73 
Sigma tablets in the appropriate amount of deionized water. Reagent kit for single cell 74 
electrophoresis assay was supplied by Trevigen (Barcelona, Spain).  75 
2.2 Synthesis of Metabolites.  76 
Synthesis of DMCPZ was achieved in two-steps following the demethylation procedure 77 
described.20. In the first step, -chloroethyl chloroformate (ACE-Cl) was added to an 78 
ethylene dichloride solution of CPZ in order to form the intermediate ACE-CPZ, whose 79 
methanolysis afforded DMCPZ hydrochloride. As regards, DDMCPZ hydrochloride it 80 
was obtained by reduction of the 7-chlorophenothiazinyl nitrile using LiAlH4. Soxhlet 81 
extraction was performed in diethyl ether for 3 days, at 40 °C as in the original procedure 82 
described for a related compound.21 Finally, CPZSO was prepared from CPZ by oxidation 83 
in aqueous nitrous acid, at room temperature, following the method reported.22. 84 
All reactions were monitored by analytical TLC with silica gel 60 F254 and revealed with 85 
ammonium molybdate reagent. The crudes were purified through silica gel 60 (0.063 – 2 86 
mm). 1H-NMR and 13C-NMR spectra were recorded in CDCl3 or CD3OD as solvents on 87 
a Bruker AC-300 at 300 and 75 MHz respectively; NMR chemical shifts are reported in 88 
ppm downfield from an internal solvent peak. 89 
DMCPZ. 1H-NMR (300 MHz, CD3OD) 2.19 (m, 2H), 2.64 (s, 3H), 3.10 (m, 2H), 4.06 90 
(t, J = 6.3 Hz, 2H), 6.94 – 6.98 (m, 1H), 7.00 – 7.11 (m, 4H), 7.16 – 7.19 (dd, J = 7.8, 1.5 91 
Hz, 1H), 7.23 - 7.28 (m, 1H). 13C-NMR (75 MHz, CD3OD) 24.7, 33.7, 45.2, 48.2, 117.4, 92 
117.6, 123.9, 124.6, 126.0, 127.0, 128.7, 129.0, 129.3, 134.7, 145.6, 147.9.  93 
DDMCPZ. 1H-NMR (300 MHz, CD3OD) 2.13 (dq, J = 14.2, 6.3 Hz, 2H), 2.98 – 3.09 94 
(m, 2H), 4.08 (t, J = 6.4 Hz, 2H), 6.95 – 7.04 (m, 2H), 7.04 – 7.10 (m, 2H), 7.13 (d, J = 95 
8.2 Hz, 1H), 7.18 (dd, J = 7.7, 1.5 Hz, 1H), 7.25 (ddd, J = 8.2, 7.3, 1.5 Hz, 1H). 13C-NMR 96 
(75 MHz, CD3OD) 6.0, 38.6, 45.2, 117.4, 117.6, 123.9, 124.6, 126.1, 127.0, 128.6, 97 
128.9, 129.3, 134.7, 145.7, 148.0. 98 
CPZSO. 1H-NMR (300 MHz, CDCl3) 2.17 (m, 2H), 2.37 (s, 6H) 2.59 (m, 2H), 4.37 99 
(m, 2H), 7.22 – 7.25 (dd, J = 8.4, 1.8 Hz, 1H), 7.30 – 7.32 (dd, J = 7.8, 1.2 Hz, 1H), 7.53 100 
– 7.55 (d, J = 8.1 Hz, 1H), 7.60 – 7.69 (m, 2H), 7.85 – 7.88 (d, J = 8.4 Hz, 1H), 7.93 – 101 
7.95 (dd, J = 7.8, 1.5 Hz, 1H). 13C-NMR (75 MHz, CDCl3) 24.3, 45.1, 45.7, 56.1, 116.3, 102 
116.4, 122.2, 122.5, 131.4, 132.6, 133.1, 138.0, 139.1, 139.6. 103 
2.3 Irradiation Equipment  104 
For all in vitro photosensitization assays, a photoreactor model LZC-4 (Luzchem, 105 
Canada) equipped with 14 lamps for top and side irradiation (max = 350 nm, Gaussian 106 
distribution) was used as the UVA light source. All irradiations were performed through 107 
the lid of the plates and the temperature was controlled by ventilation during the 108 
irradiation step. 109 
2.4 In Vitro 3T3 Neutral Red Uptake (NRU) Phototoxicity Test.  110 
BALB/c 3T3 fibroblasts cell line was grown in Dulbecco’s Modified Eagle Medium 111 
(DMEM) supplemented with 10 % Fetal Bovine Serum (FBS), 4 mM glutamine and 1% 112 
penicillin/streptomycin and routinely maintained in exponential growth in 75 cm2 plastic 113 
flasks in a humidified incubator at 37 ºC under 5 % carbon dioxide atmosphere. The 3T3 114 
Neutral Red Uptake Phototoxicity Test was performed as previously described by the 115 
OECD guideline 43223 with minor modifications. Briefly, for each compound two 96-116 
wells plates were seeded (2.5 x 104 cells / well). Cells were treated with test compounds 117 
at eight concentrations ranging from 0.5 µM to 500 µM and incubated for 1h. Next, one 118 
plate was irradiated on ice for 11 min to achieve a dose of UVA equivalent to 5 J/cm2 119 
(UVA LIGHT), whereas the other plate was kept in a dark box (DARK). The viability of 120 
UVA treated control cells was greater than 90% of those kept in the dark indicating the 121 
suitability of the UV dose. After irradiation the compound solutions were replaced with 122 
DMEM medium, and plates were incubated overnight. Next day neutral red solution (50 123 
µg/mL) was added into each well and incubated for 2 h. Cells were washed with PBS and 124 
neutral red was extracted in 100 µL with the desorbs solution (water 49 % (v / v), ethanol 125 
50 % (v / v) and acetic acid 1 % (v / v). The absorbance was measured at 550 nm on a 126 
Multiskan Ex microplate reader. For each compound dose-response curves were 127 
developed in order to determine the concentration of compound causing a 50% reduction 128 
of the neutral red uptake (IC50) in the absence and in the presence of radiation. Finally, 129 
the Photo-Irritation-Factor (PIF) was calculated using the following equation: 𝑃𝐼𝐹 =130 
 
 IC50 DARK 
IC50 UVA LIGHT
. According to the OECD Test Guideline23 a compound is predicted as 131 
phototoxic if PIF is > 5, probably phototoxic if PIF>2 and <5, and non phototoxic when 132 
PIF<2. CPZ and SDS were used as positive and negative controls, respectively.  133 
2.5 Photosensitized Damage to DNA 134 
The drug (CPZ) or its metabolites (10 µM) in 10 M PBS at pH 7.4 were added to 200 135 
ng of supercoiled plasmid pBR 322 and mixtures were irradiated as described above. 136 
After irradiation, loading buffer (0.25% bromophenol blue, 0.25% xylene cyanol, 30% 137 
glycerol 99% in water) was added to each solution immediately. To reveal specific DNA 138 
damages, irradiated mixtures were further incubated with an excess of DNA-repair 139 
enzyme (FPG, ENDO V or ENDO III) for 1h at 37 ºC, and loading buffer was then added 140 
to each solution. All the samples were loaded on a 0.8% agarose gel containing SYBR® 141 
Safe as nucleic acid stain. Electrophoresis was performed in Tris-acetate-EDTA (TAE) 142 
buffer (0.004 M Tris-acetate, 1 mM EDTA) at 100V for 1 h. Finally, the DNA bands were 143 
detected under irradiation with UV light and visualized using a Gel Logic 200 Imaging 144 
System (Kodak). The relative abundance of the supercoiled form (Form I) and the nicked 145 
relaxed form (Form II) was quantified by densitometry with the image analyzer software 146 
Quantity One (BIO RAD). 147 
2.6 Assessment of Cellular DNA Damage by Comet Assay 148 
For the detection of strand breaks and alkaline labile sites, a single cell gel electrophoresis, 149 
also known as comet assay, has been performed as described by Collins A.R et al.24, 25 with 150 
slight modifications. First, pre-coated slides were prepared by dipping degrease 151 
microscope slides in a hot 1 % normal melting point agarose solution (1w:100v MiliQ 152 
water), air dried overnight at room temperature, and then stored at room temperature 153 
avoiding high humidity conditions (pre-coated slides can be stored more than two 154 
months).  155 
The day of the experiment, fibroblasts (FSK) were trypsinized for 1 min, and after seeding 156 
250.000 cells/ml in PBS per well in three 6-well plates, cells were placed on ice and 157 
allowed to stand for 2 h before incubating them with the different chemicals. We have 158 
found that trypsin by itself induces DNA damage in the FSK cells, and that it takes 2 159 
hours to recover basal levels. Then, FSK were incubated with 10 M PBS solutions of 160 
CPZ, DCPZ, DDCPZ and positive and negative controls (CCP and CCO) supplied by 161 
Trevigen for 1 h. After the incubation time, two 6-well plates were placed in a 162 
photoreactor to irradiate the cells with UVA light on ice for 5 min, while 3rd plate of cells 163 
were immediately prepared for comet assay without irradiation. 164 
Thus, 30L of each cell suspension were mixed carefully with 140 L of 37 ºC 0.8 % low 165 
melting point agarose solution (1w:80v PBS-Ca2+/Mg2+ free) and drops of 5 L minigels 166 
were loaded on the slides. The coated-slides were placed on an ice-cold tray and twelve 167 
minigels were loaded onto each slide, being two replicates per condition. After loading, 168 
the minigels were allowed to gelify for 5 min, followed by immersion of the slides in 169 
copling Jars containing cold lysis buffer (NaCl 2.5 M, Na2EDTA 0.1 M, Tris 10 mM, Triton 170 
X-100 1% in distilled water and pH 10) and overnight incubation at 4ºC. Next day, the 171 
slides were placed in a Trevigen Comet Assay electrophoresis tank (8 slides per run), 172 
covered with 850 mL of cold alkaline electrophoresis buffer (200 mM NaOH, 1mM EDTA in 173 
distilled water and pH 13) and let during 40 min for DNA unwinding at 4º C. Afterwards, 174 
the electrophoresis was run at 21 V ( 300 mA) for 20 min at 4º C. When the 175 
electrophoresis finished, the slides were neutralized twice in PBS for 5 min and washed 176 
once with miliQ water for 1 min; DNA was fixed by slides incubation in 70% ethanol for 177 
5 min followed by other 5 min in 100 % ethanol, and then air-dried.  178 
Comet nucleoids and tails were stained by incubating the slides in a SYBR Gold (1:104 179 
TE buffer) bath for 30 min, air dried, and kept in darkness until further visualization. For 180 
nucleoids and tails DNA visualization, a distilled water drop and a cover slip were applied 181 
onto each slide and placed under an epi-fluorescence microscope with an UV-filter and  5 182 
pictures were taken for each sample. Finally, visual scoring was applied for DNA damage 183 
quantification for a total of 100 hundred DNA comets.26 Total comet score (TCS) was 184 
calculated by using a classification of 6 DNA damage categories26 and the following 185 
formula: [(Nclass 0 comets x 0) + (Nclass 1 comets x 1) + (Nclass 2 comets x 2) + (Nclass 3 comets 186 
x 3) + [(Nclass 4 comets x 4) + (Nclass 5 comets x 5) + (Nclass 6 comets x 6)]/6 and expressing 187 
results in 1-100 arbitrary units.  188 
2.7 Steady-State Photolysis.  189 
Ultraviolet absorption spectra were recorded on a Varian Cary 300 scan UV/Vis 190 
spectrophotometer. Irradiation of CPZ and its demethylated metabolites was carried out 191 
at monochromatic wavelength (330 nm) using a Xenon lamp. The progress of reactions 192 
was monitored following changes in emission spectra (exc = 330 nm). Steady-state 193 
fluorescence experiments were carried out in the wavelength range 350–650 nm using an 194 
EasyLife X (Optical Building Blocks) spectrofluorometer, equipped with a 195 
monochromator PTI. Measurements were performed in PBS (5 × 10-5 M) at room 196 
temperature using 1 cm quartz cells with 3.5 mL capacity under anaerobic conditions. 197 
2.8 Laser Flash Photolysis. Laser flash photolysis (LFP) experiments were done with a 198 
pulsed XeCl excimer laser (exc = 308 nm, ca. 17 ns pulse width, < 100 mJ per pulse) as 199 
the excitation source. In general, samples received only one pulse for all kinetic 200 
experiments. A pulsed Lo255 Oriel Xenon lamp was used as detecting light source. The 201 
observation wavelength was selected with a 77200 Oriel monochromator, and the signal 202 
amplified by an Oriel photomultiplier tube (PMT) system made up of a 77348 side-on 203 
tube, 70680 housing, and a 70705 power supply. The signal was registered with a TDS-204 
640A Tektronix oscilloscope and subsequently transferred to a personal computer. 205 
Concentrations of the samples were fixed by adjusting the absorbance of the solutions at 206 
the arbitrary value of 0.3 at the excitation wavelength. All transient spectra were recorded 207 
using 1 cm quartz cells with 3.5 mL capacity at room temperature under aerobic 208 
conditions. 209 
2.9 EPR Spin Trapping Measurements. The experiments were done in a flat cell with 210 
a Bruker EMX 10/12 EPR spectrometer, using the following parameters: microwave 211 
power, 20 mW; modulation amplitude, 1.0 G; and modulation frequency, 100 kHz. As 212 
spin-trap 2-methyl-2-nitrosopropane (MNP) was employed. Thus, analysis was 213 
performed recording the EPR signal of the MNP adduct of the aryl radical generated by 214 
loss of the chlorine atom from CPZ or its metabolites. Anaerobic PBS solutions 215 
containing the same concentration (1.4 mM) of MNP and CPZ (or one of its metabolites) 216 
were irradiated at 330 nm by means of a Xenon lamp for 3 min. 217 
3. RESULTS AND DISCUSSION 218 
3.1 Phototoxicity. 219 
Cell viability of the CPZ metabolites and photoproducts in combination with UVA light 220 
was assessed by the in vitro 3T3 NRU phototoxicity test. Thus, cytotoxicity profiles of 221 
BALB/c 3T3 fibroblasts cell treated with CPZ, PMZ, CPZSO, DMCPZ, DDMCPZ were 222 
measured in the presence of absence of UVA light, using neutral red as vital dye. 223 
This test is based on the calculation of the PIF that corresponds to the ratio of the IC50 for 224 
each chemical with and without UVA irradiation. The values obtained are given in Table 225 
1. 226 
 227 
 228 
Table 1. In vitro 3T3NRU phototoxicity assay of CPZ metabolites and photoproducts.  229 
 Compound IC50  Dark (µM) 
IC50  UVA Light 
(µM) 
Photoirritant 
Factor (PIF)
a
 
CPZ 78.6 ± 15.3 2.9 ± 0.6 27  
PMZ 113.6 ± 18.5 6.6 ± 2,5 17  
CPZSO 78.5 ± 2.7 25.2 ± 5.0 3  
DMCPZ 60.9 ± 9.4 1.8 ± 0.6 35  
DDMCPZ 66.9 ± 5.6 1.8 ± 0.3 37  
SDS 202 ± 25 244 ± 48 1  
230 
Data represent Mean±SD from five independent experiments. CPZ and SDS were used as positive and 231 
negative control of phototoxicity, respectively. aAccording to the OECD (2004), PIF<2 means “No 232 
Phototoxicity”, 2<PIF<5 means “Probably Photototoxicity” and  PIF>5 means “Phototoxicity”.  233 
 234 
The IC50 were determined from dose-response curves for cell viability of cell treated with 235 
chemicals under light or dark conditions. More details are provided in Supplementary 236 
Material.  237 
 238 
Figure 2. Phototoxicity of CPZ metabolites and photoproducts in the 3T3 NRU 239 
assay. 3T3 cells were treated with serial dilutions of CPZ metabolites ranging from 0.5 240 
µM to 500 µM for 1h, followed by irradiation or not of a dose of 5 J/cm2 UVA light. CPZ 241 
was used as a positive control of phototoxicity27 After 24 h cell viability was evaluated 242 
by neutral red uptake and IC50 values were calculated by non-lineal regression with 243 
GraphPad Prism 5.0. Data represent Mean±SD from five independent experiments and 244 
asterisks significant differences relative to the IC50 Dark by the T-Student test (**p ≥ 245 
0.01; ***p ≥ 0.001). 246 
 247 
As shown in Table 1 and Figure 2, CPZ was clearly phototoxic as expected, while 248 
promazine (dechlorinated photoproduct of CPZ) resulted less toxic upon irradiation with 249 
a PIF of ca. 17. However, DMCPZ and DDMCPZ resulted be more phototoxic (a 1.6-250 
fold increase of the IC50) than the parent drug. Both CPZ and its demethylated metabolites 251 
DMCPZ and DDMCPZ display the same chromophore. Therefore, the different behavior 252 
shown in phototoxic assays may be modulated by the alkyl chain for the lipophilicity 253 
/hydrophilicity of the different substrates. By contrast, the CPZSO metabolite did not 254 
exhibit any phototoxic potential. These results are in agreement with those obtained from 255 
the in vivo phototoxicity study by means of mouse-tail technique.28 256 
3.2 Photosensitized DNA Damage 257 
It is well known that phototoxicity involves damage to biomolecules. In particular 258 
photosensitized DNA damage is of interest since it plays an important role in 259 
photogenotoxicity and may induce lethal mutagenic and/or carcinogenic effects.29, 30 260 
Hence, irradiations of CPZ and its metabolites were performed in the presence of 261 
supercoiled circular DNA (pBR322) to detect DNA damage. Single strand breaks (ssb) 262 
can be observed directly whereas to reveal the nature of base damage the use of DNA-263 
repair enzymes is needed. 264 
 265 
Figure 3. Photogenotoxicity of CPZ and its metabolites. (A) Agarose gel 266 
electrophoresis of supercoiled DNA (pBR322, 200 ng/µL) alone or in the presence of 267 
CPZ and its metabolites (10 µM) in the dark or upon irradiation (5 min) using a multilamp 268 
photoreactor max = 355 nm. NC: Negative Control, KP: ketoprofen used as standard. (B) 269 
Formation of DNA Form II quantified by densitometry. Data represent Mean±SD from 270 
three independent experiments and asterisks significant differences relative to the 271 
formation of DNA Form II in Dark conditions by the T-Student test (**p ≥ 0.01; ***p ≥ 272 
0.001). The initial value of Form II was subtracted from all samples.  273 
 274 
Agarose gel electrophoresis (Figure 3 A) revealed a conversion of native supercoiled form 275 
I into circular form II, indicating ssb formation. Interestingly, quantification by 276 
densitometry of form II showed that DMCPZ and DDMCPZ display higher 277 
photogenotoxic potential than the parent drug (Figure 3 B). The DMCPZ and DDMCPZ 278 
metabolites resulted to be more hydrophilic and reactive than the parent drug, 279 
demonstrating that CPZ metabolism modulates the potential to photosensitize DNA 280 
damage.  281 
A) 
B) 
Different DNA–repair enzymes Endo III, Fpg and Endo V were used in order to reveal 282 
oxidized pyrimidines, oxidized purines and cyclobutane thymine dimers, respectively. In 283 
all cases, ssb formation was accentuated for DMCPZ and DDMCPZ metabolites (data 284 
reported in Supplementary Material).  285 
3.3 Photogenotoxicity detected by Comet Assay 286 
Comet assay under alkaline conditions was performed to reveal the combination of single-287 
strand breaks, double-strand breaks and alkali-labile sites in the cellular DNA. Thus, 288 
human fibroblasts (FSK) were embedded in agarose on a slide and incubated for 1 h with 289 
CPZ, DMCPZ and DDMCPZ. After 5 min of UVA exposure and immediate lysis, 290 
alkaline electrophoresis was performed. During electrophoresis, the damaged and 291 
fragmented DNA migrates away from the nucleus. Upon staining with SYBR Gold the 292 
fluorescence of the nuclei was examined and the total comet score (TCS) was calculated 293 
by using a classification of 6 DNA damage categories.26 294 
 295 
 296 
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Figure 4. (A) Top: Unexposed FSK alone or treated with 10 M of CPZ, DMCPZ and 297 
DDMCPZ. Bottom: Untreated or incubated with 10 M of CPZ and its metabolites cells 298 
upon UVA irradiation. (B) Percentage of DNA damage obtained for chemicals tested 299 
calculated by means of 6 DNA damage categories. CCO and CCP were used as positive 300 
and negative control, respectively. 301 
As shown in Figure 4, comet assays confirmed the damage induced by CPZ and its 302 
metabolites to cellular DNA, as fragmented DNA moves faster through agarose gel, 303 
forming a tail. These results are in agreement with CPZ metabolites displaying a higher 304 
photogenotoxic potential than the parent drug. 305 
3.4 Photophysical Studies 306 
3.4.1 Absorption Spectra 307 
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Figura 5. UV absorption spectra of CPZ, DMCPZ, DDMCPZ, CPZSO and PMZ in PBS 309 
at 5 × 10‒5 M. 310 
 311 
The absorption spectra of CPZ, DMCPZ, DDMCPZ and PMZ showed the typical UV-312 
Vis spectral features of the phenathiazine chromophore, while CPZSO displayed bands 313 
that absorb more in the UVA region (Figure 5). 314 
 315 
 316 
3. 4.2 Laser Flash Photolysis Studies 317 
The transient absorption spectra of CPZ (exc = 308 nm, air, flow cell) were recorded in 318 
MeCN (as model of lipophilic environment) and in aqueous medium (PBS). The 319 
normalized spectra are shown in Figure 6. The absorption band in MeCN exhibited a 320 
maximum at  = 470 nm, attributed to the triplet excited state, in agreement with literature 321 
data.31, 32  However, the maximum in PBS appeared at  = 520 nm, and was due to the 322 
CPZ radical cation.33-37 In aqueous medium, DMCPZ and DDMCPZ, exhibited both 323 
contributions from the triplet excited state and the radical cation. The decay traces 324 
monitored at  = 470 nm (PBS, air) showed that the triplet lifetimes values of the three 325 
compounds were in the submicrosecond domain and increased with the methylated 326 
degree (Figure 6B). 327 
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Figure 6. Laser flash photolysis (exc = 308 nm, air) of CPZ and its metabolites. (A): 330 
Normalized spectra of CPZ in MeCN (green), CPZ in PBS (black), DMCPZ in PBS (red) 331 
and DDMCPZ in PBS (blue), recorded 0.2 s after the laser pulse. (B): Normalized decay 332 
traces monitored at  = 470 nm in PBS/air. 333 
 334 
3.4.3 Steady-State Photolysis 335 
The course of the photoreaction of CPZ (irr = 330 nm, PBS) was followed by monitoring 336 
the changes in its fluorescence spectra. The initial emission of CPZ (exc = 330 nm/PBS) 337 
consisted of a band centered at 460 nm with quantum yield lower than 0.005. The 338 
fluorescence bands of the photomixtures were located in the same region, but their 339 
intensity increased with irradiation times (Figure 7). This is in agreement with the 340 
occurrence of a photodehalogenation reaction, leading to the corresponding promazines, 341 
whose fluorescence quantum yields are much higher. A comparison of the fluorescence 342 
intensity changes at 500 nm with irradiation times showed a similar trend for CPZ, 343 
DMCPZ and DDMCPZ (Figure 7B).  344 
B) 
400 450 500 550 600
0
200
400
600
800
In
te
n
s
it
y
 (
a
.u
.)
(nm)
 0 s
 30 s
 60 s
 90 s
 120 s
 150 s
 345 
0 50 100 150
1
2
3
4
5
 CPZ
 DMCPZ
 DDMCPZ
R
e
la
ti
v
e
 F
lu
o
re
s
c
e
n
c
e
 I
n
te
n
s
it
y
 
time (s)
 346 
Figure 7. Monitorization of irradiations by fluorescence. Conditions: irr and exc = 330 nm, 5 × 347 
10‒5, PBS, air; (A) Spectra obtained after irradiation of CPZ from 0 to 150 s; (B) Fluorescence 348 
intensity values at  = 500 nm for CPZ (black), DMCPZ (red) and DDMCPZ (blue) at different 349 
irradiation times. 350 
Electron Paramagnetic Resonance 351 
To confirm the presence of intermediates of radical nature, an EPR study was performed. 352 
As a matter of fact, the spin adducts obtained from 2-methyl-2-nitrosopropane (MNP) 353 
and the aryl radicals of CPZ, DMCPZ and DDMCPZ were observed in all cases (Figure 354 
8). This is in agreement with the photodehalogenation reaction, initiated by homolytic 355 
cleavage of the C-Cl bond. 356 
A) 
B) 
 357 
Figure 8. EPR spectra of MNP adduct of aryl radical from CPZ, DMCPZ and DDMCPZ 358 
in H2O (exc = 330 nm, N2). The concentrations of drug/metabolite and MNP were 1.4 359 
mM in all cases. 360 
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